Lincoln Pharmaceuticals Share Price

    NSE
    549
    -8.00 (1.45%)
    LINCOLN • 11 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    -15.56%

    3Y Annualised Return

    22.48%

    5Y Annualised Return

    25.97%

    The current prices are delayed, login or Open Demat Account for live prices.

    Lincoln Pharmaceuticals Stock Performance

    1W Return-2.18
    1Y Return-16.64
    Today's Low548.65
    Prev. Close557.00
    Mkt Cap (Cr.)1,101.33
    1M Return-6.72
    3Y Return84.51
    52-Week High979.5
    Open557.00
    PE Ratio13.38
    6M Return-31.60
    Today's High560.95
    52-Week Low499
    Face Value10

    Lincoln Pharmaceuticals Company background

    Founded in: 1995
    Managing director: Mahendra G Patel
    Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. 95. All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes antiinfective, respiratory system, gynecology, cardio CNS, antidiabetic, anti malaria, among others.The Company, incorporated in January, 1995, was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals.The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake inhouse testing of its products for better quality control and RD. It came out with a public issue in Feb.96 to partfinance its project.The Company launched Next Generation Progesterone Therapy ProlinSpray during the year 2018. During the year 202122, Lincoln Parenteral Limited, an erstwhile subsidiary, merged with the Company through Scheme of Amalgamation and Lincoln Parenteral Limited ceased to be a subsidiary of the Company. The Company acquired a plant in Mehsana, Gujarat to launch Cephalosporin products in 2022.

    As of 11 Jul, 2025, Lincoln Pharmaceuticals share price is ₹549.8. The stock opened at ₹557 and had closed at ₹557 the previous day. During today’s trading session, Lincoln Pharmaceuticals share price moved between ₹548.65 and ₹560.95, with an average price for the day of ₹554.80. Over the last 52 weeks, the stock has recorded a low of ₹499.00 and a high of ₹979.50. In terms of performance, Lincoln Pharmaceuticals share price has declined by 31.6% over the past six months and has declined by 15.56% over the last year.

    Read More
    Lincoln Pharmaceuticals SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹60,17,601 (-7.42%)
    Daily SIP of 25,000 would have become 60,17,601 in 1 year with a gain of -4,82,398 (-7.42%)
    View details of Market Depth

    Lincoln Pharmaceuticals Fundamental

    Market Cap (in crs)

    1,101.33

    Face Value

    10

    Turnover (in lacs)

    223.13

    Key Metrics

    Qtr Change %
    43.86% Fall from 52W High
    -0.5
    Dividend yield 1yr %
    Below industry Median
    0.3

    Lincoln Pharmaceuticals Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Lincoln Pharmaceuticals Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    168.18 Cr
    146.55 Cr
    161.21 Cr
    147.28 Cr
    142.49 Cr
    Lincoln Pharmaceuticals Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    645.71 Cr
    614.97 Cr
    532.78 Cr
    482.12 Cr
    429.85 Cr
    397.53 Cr
    Lincoln Pharmaceuticals Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    11.58 Cr
    20.77 Cr
    26.33 Cr
    23.67 Cr
    18.6 Cr
    Lincoln Pharmaceuticals Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    82.35 Cr
    93.3 Cr
    72.9 Cr
    69.36 Cr
    62.25 Cr
    51.47 Cr

    Lincoln Pharmaceuticals Result Highlights

    • Lincoln Pharmaceuticals Ltd reported a 3.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 28.5%.

    • Its expenses for the quarter were up by 0.4% QoQ and 28.1% YoY.

    • The net profit decreased 10.4% QoQ and increased 48.1% YoY.

    • The earnings per share (EPS) of Lincoln Pharmaceuticals Ltd stood at 9.3 during Q4FY25.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Top Mutual Fund Invested in Lincoln Pharmaceuticals

    Promoter
    49.8%
    Foreign Institutions
    5%
    Public
    45.2%
    Promoter
    49.8%
    Foreign Institutions
    5.2%
    Public
    45.1%
    Promoter
    49.8%
    Foreign Institutions
    5.2%
    Public
    45%
    Promoter
    49.8%
    Foreign Institutions
    4%
    Public
    46.2%
    Promoter
    49.5%
    Foreign Institutions
    3.9%
    Domestic Institutions
    0.1%
    Public
    46.5%
    Promoter
    49.8%
    Foreign Institutions
    3.2%
    Domestic Institutions
    0.1%
    Public
    46.9%

    Lincoln Pharmaceuticals Technical Analysis

    Moving Averages Analysis
    549
    Current Price
    Bullish Moving Averages
    0
    Bearish Moving Averages
    16
    5Day EMA
    557.80
    10Day EMA
    560.60
    12Day EMA
    561.30
    20Day EMA
    563.30
    26Day EMA
    564.40
    50Day EMA
    569.10
    100Day EMA
    588.70
    200Day EMA
    614.50
    5Day SMA
    560.80
    10Day SMA
    561.50
    20Day SMA
    563.80
    30Day SMA
    566.40
    50Day SMA
    568.30
    100Day SMA
    564.20
    150Day SMA
    641.50
    200Day SMA
    648.10
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    29685 Rs
    45138 Rs
    Week Rs
    26580 Rs
    54982 Rs
    Month Rs
    26004 Rs
    52816 Rs
    553.15
    Pivot
    Resistance
    First Resistance
    557.65
    Second Resistance
    565.45
    Third Resistance
    569.95
    Support
    First Support
    545.35
    Second support
    540.85
    Third Support
    533.05
    Relative Strength Index
    39.31
    Money Flow Index
    49.50
    MACD
    -3.07
    MACD Signal
    -2.04
    Average True Range
    14.25
    Average Directional Index
    11.14
    Rate of Change (21)
    -7.96
    Rate of Change (125)
    -31.92
    Name
    Holding Percent
    Rimo Capital Fund Lp
    1.33

    Lincoln Pharmaceuticals Latest News

    08 JUL 2025 | Tuesday

    Lincoln Pharmaceuticals Ltd - 531633 - Announcement under Regulation 30 (LODR)-Change in Management

    07 JUL 2025 | Monday

    Lincoln Pharmaceuticals Ltd - 531633 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    02 JUL 2025 | Wednesday

    Lincoln Pharmaceuticals Ltd - 531633 - Updates Pursuant To Regulation 30 Of The SEBI (LODR) Regulations, 2015.

    View More

    Lincoln Pharmaceuticals Share Price FAQs

    Lincoln Pharmaceuticals share price is ₹549 in NSE and ₹552 in BSE as on 11/7/2025.

    Lincoln Pharmaceuticals share price in the past 1-year return was -16.63. The Lincoln Pharmaceuticals share hit a 1-year low of Rs. 499 and a 1-year high of Rs. 979.5.

    The market cap of Lincoln Pharmaceuticals is Rs. 1101.33 Cr. as of 11/7/2025.

    The PE ratios of Lincoln Pharmaceuticals is 13.38 as of 11/7/2025.

    The PB ratios of Lincoln Pharmaceuticals is 1.64 as of 11/7/2025

    You can easily buy Lincoln Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Lincoln Pharmaceuticals share price is ₹979.5 and ₹499 as of 11/7/2025.

    Please be aware that Lincoln Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.92
    -0.05 (-0.08%)
    135.28
    -1.85 (-1.35%)
    681.80
    -13.80 (-1.98%)
    2,558.70
    -22.30 (-0.86%)
    160.00
    -9.64 (-5.68%)
    381.65
    -3.05 (-0.79%)
    159.84
    -0.82 (-0.51%)
    263.35
    +0.50 (+0.19%)
    409.30
    -4.20 (-1.02%)
    396.85
    -3.05 (-0.76%)
    Top Gainers
    2,519.60
    +111.20 (+4.62%)
    1,835.20
    +25.00 (+1.38%)
    1,173.80
    +9.50 (+0.82%)
    2,220.60
    +16.80 (+0.76%)
    858.85
    +6.00 (+0.70%)
    Top Losers
    3,266.00
    -116.00 (-3.43%)
    3,073.20
    -89.20 (-2.82%)
    8,067.00
    -218.00 (-2.63%)
    258.30
    -6.75 (-2.55%)
    4,218.70
    -102.60 (-2.37%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -